These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents]. Knipping W Med Klin; 1980 Feb; 75(3):108-15. PubMed ID: 7374607 [No Abstract] [Full Text] [Related]
8. [Incompatibility and interference of the major cardiologic drugs. Their undesirable effects]. Barrillon A; Grand A Rev Prat; 1976 Dec; 26(59):4239-46. PubMed ID: 794985 [No Abstract] [Full Text] [Related]
10. Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension. Lloyd BL; Greenblatt DJ J Clin Psychopharmacol; 1981 Nov; 1(6):394-8. PubMed ID: 7334149 [No Abstract] [Full Text] [Related]
11. [Drug therapy of arrhythmia--its therapeutic and adverse effects]. Nohara Y Nihon Rinsho; 1968 Aug; 26(8):1884-98. PubMed ID: 4888917 [No Abstract] [Full Text] [Related]
12. Torsades de pointes, a common arrhythmia, induced by medication. Ko PT; Gulamhusein S; Kostuk WJ; Klein GJ Can Med Assoc J; 1982 Sep; 127(5):368-72. PubMed ID: 7104914 [TBL] [Abstract][Full Text] [Related]
13. Cardiac arrhythmias. Rationale of drug therapy. Chung EK Singapore Med J; 1973 Sep; 14(3):325-33. PubMed ID: 4591402 [No Abstract] [Full Text] [Related]
14. [Clinical pharmacology and adverse effects of various anti-arrhythmic drugs]. Bleifeld W; Merx W; Effert S Dtsch Med Wochenschr; 1971 Apr; 96(16):671-9. PubMed ID: 4397010 [No Abstract] [Full Text] [Related]
15. Special considerations in the use of cardiovascular drugs. Ueland K; McAnulty JH; Ueland FR; Metcalfe J Clin Obstet Gynecol; 1981 Sep; 24(3):809-23. PubMed ID: 7026105 [No Abstract] [Full Text] [Related]
16. [Side effects of anti-arrhythmic agents]. Golochevskaia VS Klin Med (Mosk); 1971 Oct; 49(10):11-5. PubMed ID: 4109038 [No Abstract] [Full Text] [Related]
18. Rational use of antiarrhythmic drugs alone and in combination. Bigger JT; Giardina EG Cardiovasc Clin; 1974; 6(2):103-17. PubMed ID: 4613454 [No Abstract] [Full Text] [Related]
19. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats]. Ammar EM; Kudrin AN Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670 [No Abstract] [Full Text] [Related]
20. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion? Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]